Reports that trials to evaluate testosterone replacement therapy for men are to remain on hold pending publication of a review by an independent panel of experts. Recommendations of the Institute Medicine task force due in November 2003; Design, safety and ethics of clinical trials; Concerns about cancer and other potential side effects.